Integrative Use of Sound Therapy for Mental Health Promotion
Integrative Use of Sound Therapy for Mental Health Promotion: A Randomized Clinical Trial
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
- Mental health disorders such as anxiety, stress, and depression are prevalent global health issues. Sound therapy is proposed as an integrative complementary therapy to address these conditions. This prospective randomized open-label study involves 110 participants.
- Participants will be randomized into:
> 1. *Intervention Group:* Receives sound therapy inside a specifically designed acoustic resonance chamber.
> 2. *Control Group:* Receives the same sound therapy sequence using headphones, without the chamber.
- The intervention consists of three weekly sessions of 9 minutes each. The sound protocol uses nine specific frequencies (ranging from 174 Hz to 936 Hz) derived from a 432 Hz tuning reference. Outcomes will be measured using validated scales including DASS-21, WHOQOL-Bref, and others at baseline, during the intervention, and at 30-day and 120-day follow-ups.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brasil, 30130-100
- Federal University of Minas Gerais
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria
- Age over 18 years
- DASS-21 score consistent with at least mild anxiety, stress, or depression
- Agreement to complete the 3-week protocol and follow-up questionnaires
- Agreement not to practice other mind-body therapies during the study
- Maintenance of conventional medical and/or psychological treatments
Exclusion Criteria
- Normal scores on the DASS-21
- Presence of severe neurological, psychiatric, or clinical disorders
- Use of high doses of medication that prevent standing for 9 minutes
- Use of metal plates or devices in the body
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Acoustic Resonance Chamber
Participants listen to specific sound frequencies inside a cylindrical acoustic resonance chamber (190 cm high and 90 cm in diameter), designed to optimize sound pressure distribution.
Sessions last 9 minutes, once a week, for 3 weeks.
|
Participants will receive sound therapy in 3 sessions, one session per week, each lasting 9 minutes.
The protocol uses 9 sound frequencies as follows: session 1 will use the frequencies of 396 Hz (close to the note G), 639 Hz (close to the note E), and 963 Hz (close to the note B); session 2 will use the frequencies of 174 Hz (close to the note F), 417 Hz (close to the note G sharp), and 741 Hz (close to the note F sharp); and session 3 will use the frequencies of 285 Hz (close to the note D), 528 Hz (close to the note C), and 852 Hz (close to the note A), with each frequency applied for three minutes.
Sound therapy is performed inside an acoustic resonance chamber, designed to optimize sound pressure distribution.
|
|
Comparador Ativo: Control Group with Headphones
Participants listen to exactly the same sound frequencies, for the same duration (9 minutes, once a week, for 3 weeks), using headphones while remaining seated in a chair, outside the acoustic chamber environment.
|
Participants will receive sound therapy in 3 sessions, one session per week, each lasting 9 minutes.
The protocol uses 9 sound frequencies as follows: session 1 will use the frequencies of 396 Hz (close to the note G), 639 Hz (close to the note E), and 963 Hz (close to the note B); session 2 will use the frequencies of 174 Hz (close to the note F), 417 Hz (close to the note G sharp), and 741 Hz (close to the note F sharp); and session 3 will use the frequencies of 285 Hz (close to the note D), 528 Hz (close to the note C), and 852 Hz (close to the note A), with each frequency applied for three minutes.
Participants receive the sound protocol through headphones, while remaining seated.
|
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from Baseline in Depression, Anxiety, and Stress Scores
Prazo: Baseline, Day 7 post-intervention, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the 21-item Depression, Anxiety, and Stress Scale (DASS-21).
It assesses the severity of the core symptoms of depression, anxiety, and stress.
It consists of three subscales.
The total score for each subscale is calculated by summing the scores of the 7 relevant items (scored from 0 to 3) and multiplying by 2. Therefore, final scores for each subscale range from 0 to 42.
Higher scores indicate greater symptom severity.
|
Baseline, Day 7 post-intervention, Day 30 post-intervention, and Day 120 post-intervention.
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from Baseline in Quality of Life
Prazo: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the World Health Organization Quality of Life-BREF (WHOQOL-BREF).
The total scores for the domains are transformed to a scale ranging from 0 to 100.
Higher scores indicate a better quality of life.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in Insomnia Severity
Prazo: aseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the Insomnia Severity Index (ISI).
Total scores range from 0 to 28.
Higher scores indicate more severe insomnia.
|
aseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in Human Flourishing
Prazo: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the Harvard Human Flourishing Program measure.
The instrument consists of 12 items scored on a scale of 0 to 10.
The total score (Secure Flourish Index) ranges from 0 to 120.
Higher scores indicate a higher level of psychosocial prosperity and flourishing.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in Religiosity
Prazo: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the Duke University Religion Index (DUREL).
The total score ranges from 5 to 27.
Higher scores indicate greater religious involvement and religiosity.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in General Health
Prazo: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
ssessed using the 12-item General Health Questionnaire (GHQ-12).
It evaluates psychological distress and current mental health.
Scores are scaled from 0 to 36 (using the 0-1-2-3 Likert scoring method).
Higher scores indicate worse psychological well-being and higher levels of distress.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in Alcohol Use
Prazo: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the Alcohol Use Disorders Identification Test (AUDIT).
This 10-item screening tool measures alcohol consumption, drinking behaviors, and alcohol-related problems.
Total scores range from 0 to 40.
Higher scores indicate more hazardous and harmful alcohol use.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Cadeira de estudo: Laylla CS Gendiroba, MSc, Federal University of Minas Gerais
- Cadeira de estudo: UBIRATAN B Castro, MD, PhD, Federal University of Minas Gerais
- Cadeira de estudo: Martinho M Sousa Filho, MD, MSc, Federal University of Minas Gerais
- Investigador principal: Rubens L C Tavares, MD, PhD, Federal Universtiy of Minas Gerais
Publicações e links úteis
Publicações Gerais
- Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, Pinzon V. [Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref]. Rev Saude Publica. 2000 Apr;34(2):178-83. doi: 10.1590/s0034-89102000000200012. Portuguese.
- Aravena PC, Almonacid C, Mancilla MI. Effect of music at 432 Hz and 440 Hz on dental anxiety and salivary cortisol levels in patients undergoing tooth extraction: a randomized clinical trial. J Appl Oral Sci. 2020;28:e20190601. doi: 10.1590/1678-7757-2019-0601. Epub 2020 May 11.
- VanderWeele TJ. On the promotion of human flourishing. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8148-8156. doi: 10.1073/pnas.1702996114. Epub 2017 Jul 13.
- Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. J Affect Disord. 2014 Feb;155:104-9. doi: 10.1016/j.jad.2013.10.031. Epub 2013 Oct 28.
- Lucchetti G, Granero Lucchetti AL, Peres MF, Leao FC, Moreira-Almeida A, Koenig HG. Validation of the Duke Religion Index: DUREL (Portuguese version). J Relig Health. 2012 Jun;51(2):579-86. doi: 10.1007/s10943-010-9429-5.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Transtornos Mentais, Desordem Mental
- Sintomas Comportamentais
- Comportamento
- Satisfação pessoal
- Transtornos de ansiedade
- Depressão
- Estresse, Psicológico
- Bem-estar psicológico
- Técnicas de investigação
- Design de pesquisa epidemiológica
- Métodos epidemiológicos
- Design de pesquisa
- Métodos
- Grupos de controle
Outros números de identificação do estudo
Outros números de identificação do estudo
- CAAE 84185724.2.0000.5149
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CIF
- ANALYTIC_CODE
- CSR
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .